medigraphic.com
ISSN 1025-0298 (Electronic)
ISSN 1025-028X (Print)

2020, Number 3

<< Back Next >>

VacciMonitor 2020; 29 (3)

Characterization of allergic patients to bee sting that receive immunotherapy

Bocourt-Esmeiro FM, López-González B, Álvarez-Castelló M, Castro-Almarales RL, Rodríguez-Canosa JS, Torres-Concepción J

Language: Spanish
References: 17
Page: 129-135
PDF size: 293.56 Kb.


ABSTRACT

Allergy to bee venom may cause from mild to severe reactions threatening the patient´s life. Immunotherapy with hymenopter venom is an effective treatment that can protect allergic patients from suffering systemic reactions to new stings. The aim of this study was to characterize allergic patients to bee sting that receive immunotherapy. A descriptive longitudinal observational study was carried out in allergic patients to bee sting receiving immunotherapy with bee extracts in the University Hospital General “Calixto García”, Havana, Cuba. A sample of 17 patients with inclusion criteria was analyzed. Descriptive statistical techniques were used: mean, probability, standardized score, as well as, inferential statistic techniques such as the Chi square; verifying significant association between variables. The level of signification was 5% (p˂0.05).The third decade of life was the average age of the patients in this study; male sex and, urban residents were predominant. Around half of the patients had rhinitis and family history of asthma. All patients had local reactions; most of the patients were re-exposed to stings. Only 20% of patients reported systemic allergic reaction after immunotherapy. Skin reactivity to bee extract was reduced with the immunotherapy.


REFERENCES

  1. Golden DB, Marsh DG, Freidhoff LR, Kwiterovich KA, Addison B, Kagey-Sobotka A, et al. Natural history of hymenoptera vemon sensitivity in adults. J Allergy Clin Immunol. 1997;100:760-6. doi:10.1016/s0091-6749(97)70270-7.

  2. Mora A, Pajarón MJ, Funes-Vera E. Medidas preventivas e inmunoterapia específica. En: Miralles JC, Negro JM. Guía de Alergia a Himenópteros. Murcia: ALK Abelló; 2012. p.47-57.

  3. Schiener M, Graessel A, Oller M, Schimidt-Weber CB, Blank S. Allergen-specific immunotherapy of Hymenoptera venom allergy also a matter of diagnosis. Hum Vaccin Immunother. 2017;13(10):2467-81. doi: 10.1080/21645515.2017.1334745.

  4. Hunt KJ, Valetine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A Controlled Trial of Immunotherapy in Insect Hypersensitivity. N Engl J Med. 1978;299:157-61 Disponible en: http://doi.org/10.1056/NEJM197807272990401.

  5. Sturm GJ, Varga EM, Roberts G, Mosbech H, Biló MB, Akdis CA, et al. EAACI guidelines on Allergen Immunotherapy: Hymenoptera venom allergy. Allergy. 2017; 73(4):1-51. doi: 10.1111/all.13262.

  6. Biló BM, Ruëff F, Mosbech H, Bonofazi F, Oude-Elberink JNG, Birnbaum J, et al. Diagnosis of Hymenoptera Venom Allergy. Allergy. 2005;60:1339-49. doi: 10.1111/j.1398-9995.2005.00963.x.

  7. Guspi-Bori R, Ferré-Ybarz L, Ranea-Arroyo S, Nevot-Falco S. Alergia a picadura de insectos. Pediatr Integral. 2005;(8):611-9. Disponible en: https://es.scribd.com/document/54063066/Alergia-picadura-insectos-1.

  8. Martínez-Cañavate A, Tabar AI, Eseverri JL, Martín F, Pedemonte-Marco C. An epidemiological survey of hymenoptera venom allergy in the Spanish paediatric population. Allergol Immunopatol. 2010;38(5):259-62. doi:10.1016/j.aller.2010.02.004.

  9. Simons FER, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Kase-Tanno L, et al. 2015 update of the evidence base: World Allergy Organization Anaphylaxis guidelines. World Allergy Organ J. 2015;8:32. doi:10.1186/s40413-015-0080-1.

  10. Dreborg S, Frew A. Position paper: Allergen standardization and Skin tests. The European Academy of Allergen Clinic Inmunol. Allergy. 1993;48(14):49-54. Disponible en: https://doi.org/10.1111/j.1398-9995.1993.tb04756.x.

  11. Centro Estatal de Control de Medicamentos y Dispositivos Médicos (CECMED). Regulación No. 30-2002. Requisitos para las solicitudes de inscripción en el registro de medicamentos de uso humano de productos alergénicos. La Habana: CECMED; 2002. Disponible en https://www.cecmed.cu/sites/default/file/adjuntos/Reglamentacion/Reg_30-2.pdf.

  12. World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191-4. doi:10.1001/jama.2013.281053.

  13. Becerril-Ángeles M, Núñez-Velázquez M, Grupo del Programa nacional de Control de la Abeja Africana SAGARPA. Factores de riesgo de alergia al veneno de abeja en apicultores mexicanos. Rev Alergia Mex. 2013;60(3):100-4. Disponible en: https://www.medigraphic.com/pdfs/revalemex/ram-2013/ram133c.pdf.

  14. Vega-Castro A, Marqués-Amat L, Alonso-Llamazares A, Baltasar-Drago M, Cruz-Granados S, Dalmau-Duch G, et al. Recomendaciones y algoritmos de práctica clínica de la Sociedad española de Alergología e Inmunología Clínica. Guía Alergia a himenópteros. Madrid: Equalmás 5; 2010. Disponible en: https://www.seaic.org/wp-content/uploads/2019/07/Algoritmoshimenopteros.pdf.

  15. Ruëff F, Vos B, Oude-Elberink J, Bender A, Chatelain R, Dugas-Breit S, et al. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy. Clin Exp Allergy. 2014;44(5):736-46. doi: 10.1111/cea.12275.

  16. Navarro LA, Peláez A, de la Torre F, Tenias-Burillo JM, Megías J, Martínez I. Epidemiological factors of hymenoptera venom allergy in a Spanish adult population. J Investig Allergol Clin Immunol. 2004;14(2):134-41. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15301303.

  17. Armisén M, Vidal C, López-Carballo C, Purriños MJ, Fernández-Ovide E, Piñeiro J. Alergia a veneno de himenópteros: epidemiología del área sanitaria de Santiago de Compostela. Alergol Inmunol Clin. 2001;16:213-6. Disponible en: https://www.revista.seiac.org/agosto2001/213-216.pdf.




2020     |     www.medigraphic.com